Fifth European progress in vaccination against cancer conference, PIVAC 5

Cancer Immunol Immunother. 2006 Jul;55(7):884-90. doi: 10.1007/s00262-005-0120-8. Epub 2006 Jan 12.
No abstract available

Publication types

  • Congress

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology
  • Breast Neoplasms / therapy
  • Cancer Vaccines / therapeutic use*
  • Clinical Trials as Topic
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB-2
  • HLA Antigens / immunology
  • Humans
  • Immunity, Innate
  • Immunotherapy / methods
  • Jurkat Cells
  • Melanoma / genetics
  • Melanoma / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Oncogenes
  • RNA, Small Interfering / therapeutic use
  • Rats
  • Receptor, ErbB-2 / immunology
  • Receptors, Antigen, T-Cell / immunology
  • Recoverin / immunology
  • Treatment Outcome
  • Vaccination*
  • Vaccines, Synthetic / immunology

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines
  • HLA Antigens
  • RNA, Small Interfering
  • Receptors, Antigen, T-Cell
  • Vaccines, Synthetic
  • Recoverin
  • Receptor, ErbB-2